Abstract Submission Form
Abstract Deadline: Monday, November 15, 2021, 11:59 PM PT
* - required field
Individual(s) Ethan Kung1, Allessandro Giardini2, T-Y Hsia2, Alison Marsden1, MOCHA Investigators2
Institution(s) 1UCSD, La Jolla, CA; 2Great Ormond Street Hospital for Children, London, United Kingdom
Learners participating in all formats of CME activities sponsored, co-sponsored, or jointly provided by the Cine-Med must be provided the opportunity to properly evaluate the objectivity of the information, analysis, and recommendations presented during an activity. It is important that the learners be informed of any aspect of personal or professional circumstance, originating with anyone in a position to control educational content, out of which a perception of a conflict of interest would arise.
An ineligible company is defined by the ACCME as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, with some exceptions, such as, eligible non-profit or government organizations, non-health care related companies, and providers of clinical service directly to patients. Circumstances calling for disclosure include, but are not limited to: receipt of financial support from an ineligible company, as defined above, for research activities or other scientific work reported on during the program, or, a personal financial or proprietary interest in, or consultant relationship to, a company that is a commercial supporter of the activity or whose product or service is discussed as part of the subject matter of the activity. Specifically, any financial relationship in any amount occurring in the last twenty four (24) months (even if the relationship has been divested), including those of a spouse/partner, must be disclosed.
A conflict of interest exists wherein an individual has or uses the opportunity to inject bias based on the held financial interest into the educational content or dissemination of related information. According to the ACCME, financial relationships create actual conflicts of interest in CME when individuals have both a financial relationship with an ineligible company and the opportunity to affect the content of CME about the products or services of that ineligible company, as defined above.
Based on the above, ALL CME-related persons involved with content, including committee members, activity chairs/co-chairs, reviewers, presenters, moderators, authors, editors, staff, and others as applicable, must:
Please provide information in table for the last 24 months and use actual corporate names. (Trade names or product group messages will not be published, therefore only component or generic names may be used, IF needed to clarify a financial relationship or affiliation.
NOTE: ACCME does NOT require disclosure of CME speaker/author honoraria if it is from an accredited provider.
* Royalty recipient, grant recipient, employee, intellectual property rights holder, independent contractor, board member, review panel member, patent holder, expert witness, speakers’ bureau member, etc. are examples of other terminology used to describe the nature of a financial relationship with an ineligible company.
If you have disclosed a financial interest please review the following, which lists the mechanisms have been identified for resolving conflict of interest. If a real or apparent conflict of interest is disclosed above, please check all that apply:
* Have you disclosed a financial interest?
Actions to be taken for final resolution of conflict of interest (COI) will be approved or directed by the CME Planning Committee/Program Chairs, etc. responsible for oversight of the CME activity. Alternate suggestions for resolving specific conflicts of interest may be discussed with the appropriate persons responsible for planning the activity.
Acceptance of Responsibility
All the recommendations involving clinical medicine in a CME activity are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindication in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. Within my role(s) in this activity, I will ensure balance, independence, objectivity, and scientific rigor.
I attest that I have read the above responsibilities and will comply; the information I submit is accurate.
Required Signature (First and Last Name): *